zepbound
(tirzepatide)Eli Lilly and Company
Usage: ZEPBOUND® is indicated for weight reduction and long-term maintenance in adults with obesity or overweight plus weight-related conditions, and for treating moderate to severe obstructive sleep apnea in obese adults, alongside a reduced-calorie diet and increased physical activity. Coadministration with other tirzepatide or GLP-1 products is not recommended.